James Aloysius Brady, Director at Verona Pharma plc (VRNA), sold 824 shares at $13.14 ($11K) on 2025-08-01, disclosed to the SEC on 2025-08-05.
Open-market sale of $11k VRNA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.